What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians

被引：3
|
作者：
Massie, BM [1 ]
机构：
[1] Vet Affairs Med Ctr, Cardiol Sect, San Francisco, CA 94121 USA
来源：
JOURNAL OF CARDIAC FAILURE | 2002年 / 8卷 / 04期
关键词：
D O I：
10.1054/jcaf.2002.127612
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：197 / 201
页数：5
相关论文
共 50 条
  • [1] Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension (LIFE) study
    Devereux, RB
    Lyle, PA
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) : 2311 - 2320
  • [2] Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial
    Devereux, RB
    Dahlöf, B
    Gerdts, E
    Boman, K
    Nieminen, MS
    Papademetriou, V
    Rokkedal, J
    Harris, KE
    Edelman, JM
    Wachtell, K
    CIRCULATION, 2004, 110 (11) : 1456 - 1462
  • [3] The Losartan Intervention for Endpoint reduction (LIFE) in Hypertension study - Rationale, design, and methods
    Dahlof, B
    Devereux, R
    deFaire, U
    Fyhrquist, F
    Hedner, T
    Ibsen, H
    Julius, S
    Kjeldsen, S
    Kristianson, K
    LederballePedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (07) : 705 - 713
  • [4] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Dahlöf, B
    Devereux, RB
    Kjeldsen, SE
    Julius, S
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristiansson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    LANCET, 2002, 359 (9311): : 995 - 1003
  • [5] Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
    Devereux, Richard B.
    Dahlof, Bjorn
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (02) : 443 - 457
  • [6] New-onset diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE)
    Lindholm, LH
    Ibsen, H
    Borch-Johnsen, K
    Olsen, MH
    Wachtell, K
    Dahlof, B
    Devereux, RB
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Kristianson, K
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Aurup, P
    Edelman, J
    Snapinn, S
    CIRCULATION, 2002, 106 (19) : 573 - 573
  • [7] Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients -: The Losartan intervention for endpoint reduction in hypertension (LIFE) study
    Okin, PM
    Devereux, RB
    Nieminen, MS
    Jern, S
    Oikarinen, L
    Viitasalo, M
    Toivonen, L
    Kjeldsen, SE
    Dahlöf, B
    CIRCULATION, 2006, 113 (01) : 67 - 73
  • [8] Regression of electrocardiographic left ventricular hypertrophy by Losartan versus atenolol -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study
    Okin, PM
    Devereux, RB
    Jern, S
    Kjeldsen, SE
    Julius, S
    Nieminen, MS
    Snapinn, S
    Harris, KE
    Aurup, P
    Edelman, JM
    Dahlöf, B
    CIRCULATION, 2003, 108 (06) : 684 - 690
  • [9] Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
    Lindholm, LH
    Ibsen, H
    Dahlöf, B
    Devereux, RB
    Beevers, G
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Kristiansson, K
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Aurup, P
    Edelman, J
    Snapinn, S
    LANCET, 2002, 359 (9311): : 1004 - 1010
  • [10] The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin -: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study
    Fossum, E
    Moan, A
    Kjeldsen, SE
    Devereux, RB
    Julius, S
    Snapinn, SM
    Edelman, JM
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kristianson, K
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wedel, H
    Dahlöf, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (05) : 770 - 775
12345